Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

David J. Inwards, P. A. Fishkin, B. R. LaPlant, M. T. Drake, P. J. Kurtin, D. A. Nikcevich, D. B. Wender, B. S. Lair, T. E. Witzig

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences